Biotechnology Companies By Short Ratio

Short Ratio
Short RatioEfficiencyMarket RiskExp Return
1IMRX Immuneering Corp
54.36
(0.07)
 5.21 
(0.34)
2GALT Galectin Therapeutics
44.38
 0.00 
 3.68 
 0.02 
3PROK ProKidney Corp
31.19
 0.05 
 6.42 
 0.32 
4TRDA Entrada Therapeutics
29.36
 0.01 
 4.39 
 0.04 
5JANX Janux Therapeutics
28.15
 0.16 
 29.94 
 4.69 
6STOK Stoke Therapeutics
27.76
 0.19 
 6.52 
 1.22 
7OCX OncoCyte Corp
27.05
(0.05)
 6.59 
(0.31)
8BYSI BeyondSpring
26.81
 0.15 
 5.55 
 0.81 
9QNCX Cortexyme
25.08
 0.14 
 3.83 
 0.52 
10CVM CEL SCI Corp
24.5
(0.10)
 4.12 
(0.41)
11PLX Protalix Biotherapeutics
23.87
 0.06 
 3.14 
 0.18 
12OVID Ovid Therapeutics
23.55
 0.05 
 3.04 
 0.15 
13GOSS Gossamer Bio
22.8
 0.14 
 5.52 
 0.77 
14DAWN Day One Biopharmaceuticals
22.54
 0.17 
 3.59 
 0.60 
15FENC Fennec Pharmaceuticals
22.47
 0.03 
 2.33 
 0.08 
16MOLN Molecular Partners AG
22.09
 0.03 
 5.17 
 0.14 
17SRRK Scholar Rock Holding
21.7
 0.05 
 4.17 
 0.20 
18AURA Aura Biosciences
21.22
 0.06 
 3.17 
 0.19 
19LYEL Lyell Immunopharma
20.79
 0.17 
 4.80 
 0.83 
20CARM Carisma Therapeutics
20.63
 0.02 
 4.59 
 0.07 
The analysis above is based on a 90-day investment horizon and a default level of risk. Use the Portfolio Analyzer to fine-tune all your assumptions. Check your current assumptions here.
Short Ratio is typically used by traders and speculators to identify trends in current market sentiment for a particular equity instrument. In its simple terms this ratio shows how many days it will take all current short sellers to cover their positions if the price of a stock begins to rise. The higher the Short Ratio, the longer it would take to buy back the borrowed shares. In theory, the more short positions are currently outstanding, the faster it will be to cover shorted positions.